Disinfectant Exposure Reduction and Control:
SARS-CoV-2 Disinfection Guidance for All Industries | Disinfectant Use in Biopharma and Healthcare Industries
Earn 1.5 Contact Hours
Member $140 | Nonmember $175 | Student $25
Participating as part of a group? Learn more here.
Uncontrolled use of disinfectants and overexposure can potentially result in an occupational illness, which is why a focus on safe selection of disinfectant and exposure reduction is needed.
In the face of the corona virus pandemic, we are learning about indiscriminate use of disinfectants to disinfect SARS-CoV-2 in all types of industries. Healthcare facilities and biopharma industries are also at risk for potential disinfectant exposure.
This webinar will share lessons learned on disinfectant selection and exposure reduction from statistical analysis of 2000+ disinfectant exposure monitoring data points, including disinfectants of choice, work practices contributing to exposures (spray vs. wipe), impact of room ventilation, and recommendations on the safe use of disinfectants and respiratory protection.
You will also receive guidance on the most effective disinfectants for SARS-CoV-2, UV disinfection, and COVID-19 surface testing.
- Discuss the selection of safe disinfectants which provide disinfectant efficacy and protect the health of disinfectant users
- Analyze the exposure profile of most used disinfectants which aids in the selection of disinfectants and exposure controls
- Identify safe disinfection application techniques e.g., spray vs. wipe
Maharshi Mehta, CIH, CSP, FAIHA, Global Director, International Safety Systems, Inc.
Maharshi has 30+ years of experience in industrial hygiene conducting industrial hygiene, safety assessments and EHS audits at 300+ workplaces in 30+ countries. Maharshi has collected and or analyzed 2000+ disinfectant exposure and area air monitoring results in pharmaceutical and other industries. Maharshi has conducted more than 100 training programs and webinars on industrial hygiene, process safety, laboratory safety and other related subjects. Maharshi is recipient of two President’s award from AIHA.
Brian Petuch, CBSP, RBP, Project Manager, Bio-Safety, International Safety Systems, Inc.
Brian is Certified Biosafety Professional (CBSP) and Registered Biosafety Professional (RBP) with more than 30 years’ experience as Corporate Biosafety Officer with a leading biopharmaceutical firm. Brian is a globally recognized Biosafety expert and a member of the American Biological Safety Association International (ABSA). Brian has taught webinars on multiple subjects including Large Scale Biosafety reviewing regulations, technology, risk assessment and emergency preparedness. Brian was awarded the Everett Hanel, Jr. Presidential Award in 2016 for contributions to ABSA .International. He is a coauthor of the large-scale biosafety appendix soon to be published in Biosafety in Microbiological and Biomedical Laboratories (BMBL) 6th edition from US CDC/NIH.
Questions? Contact firstname.lastname@example.org.